Table 1.
Characteristics of responders (participants in the 7-year follow-up) by treatment group
| Mesh (n = 58) | Native tissue (n = 69) | Difference (95% CI) | |
|---|---|---|---|
| Age at time of surgery (years) | 60.9 ± 9.0 | 62.4 ± 10.2 | −1.5 (−5.1, 1.7) |
| Age at follow-up (years) | 67.1 ± 8.9 | 68.8 ± 9.9 | −1.7 (−5.1, 1.7) |
| Follow-up (months) | 84 (65–98) | 84 (65–99) | 0 (−3.0, 3.0) |
| Parity (n) | 2 (1–6) | 2 (1–5) | 0 (0, 0) |
| BMI (kg/m2) | 26.4 ± 4.1 | 26.8 ± 4.3 | −0.4 (−2.0, 1.1) |
| Prior number of POP surgeries | 1 (1–3) | 1 (1–3) | 0 (0, 0) |
| Prior number of treated vaginal compartments | 2 (1–3) | 2 (1–3) | 0 (0, 0) |
| POP-Q stage at time of surgery | |||
| • Stage II | 33 (57) | 36 (52) | 5 (−13, 22) |
| • Stage III | 24 (41) | 31 (45) | −4 (−21, 14) |
| • Stage IV | 1 (2) | 2 (3) | −1 (−6, 4) |
| Pain at baseline | |||
| • Yes | 26/55 (47) | 35/58 (60) | −13 (−31, 5) |
| • UDI pain score | 26.1 (24.2, 28.0) | 28.8 (26.3, 31.3) | −2.6 (−10.9, 5.6) |
| Dyspareunia at baseline | |||
| • Moderate to quite a bit | 11/53 (21) | 15/58 (26) | −5 (−21, 11) |
| • Yes | 18/53 (34) | 27/58(46) | −12 (−31, 6) |
| Composite success and pain score at 1 year | |||
| • Composite success; n [%: (95% CI)] | 40/53 [76: (62, 85)] | 43/58 [74: (62, 84)] | 2 (−15, 18) |
| • UDI Pain score; n (CI) | 13.2 (11.4, 15.0) | 15.1 (13.5, 16.7) | −1.8 (−8.5, 4.9) |
Data presented as mean ± standard deviation (SD), median (range), n (%), I [%: (95% CI)], % (95% CI), or mean (95% CI)
BMI body mass index, POP-Q Pelvic Organ Prolapse Quantification system, UDI pain score urodynamic pain score, 0–100, CI confidence interval